NANOFORM FINLAND OYJ |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.465 EUR | -2.38% |
|
-7.85% | +55.52% |
| Apr. 11 | Nanoform Finland to Deliver Nanomedicine Technology to Japan | MT |
| Apr. 11 | Nanoform Enters Exclusive Partnership with CBC to Bring Best-In-Class Nanomedicine Technology to Japan | CI |
Chart calendar Nanoform Finland Oyj
3e18eac830bf2743098977.VSNnmCthVxlPIGkqypQvXwHqyE2GjZPEjU-Uap8Vyyk.eFMk9UEzL2E9fwpPhqVJEGmkuirnz6Wx0hjlO9FS_GRnSVPhYVQSTixWLA~1997ba047e2d61bf1d2d77d2caf56cea
Upcoming events on Nanoform Finland Oyj
Past events on Nanoform Finland Oyj
| 2024-04-16 03:00 am | Annual General Meeting |
| 2024-03-17 | BioEurope Spring Conference |
| 2024-02-29 08:00 am | Q4 2023 Earnings Call |
| 2024-02-29 01:10 am | Q4 2023 Earnings Release |
| 2023-12-13 | DNB Nordic Healthcare Conference |
| 2023-12-05 | DDL Conference |
| 2023-11-28 | Nordic Life Science Conference |
| 2023-11-27 | BOS Conference |
| 2023-11-22 | SEB Healthcare Seminar |
| 2023-11-22 08:00 am | Q3 2023 Earnings Call |
| 2023-11-22 01:10 am | Q3 2023 Earnings Release |
| 2023-11-15 | Pharma Integrates Conference |
| 2023-11-07 | CNS Summit |
| 2023-11-05 | Bio-Europe Conference |
| 2023-10-23 | CPhI Conference |
| 2023-10-21 | AAPS PharmSci 360 Conference |
| 2023-10-15 | PODD Conference |
| 2023-09-25 | Bio Conference |
| 2023-09-20 | PharmaTech Integrates Comference |
| 2023-09-17 | DDF Summit |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,69 1,45 -52.62% | 2,00 2,05 -2.44% | 3,49 3,75 -7.01% | 2,57 3,09 -16.82% | 7,49 |
|
EBITDA Million EUR | Released Forecast Spread | -18,2 -19,2 5.23% | -17,7 -19,0 6.6% | -19,0 -19,1 0.38% | -19,6 -18,8 -4.38% | -13,1 |
|
EBIT Million EUR | Released Forecast Spread | -19,4 -18,9 -3.04% | -19,7 -20,1 1.75% | -21,4 -21,5 0.42% | -22,5 -21,6 -4.15% | -16,4 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -19,4 -19,3 -0.72% | -19,7 -20,2 2.54% | -22,1 -21,9 -0.71% | -20,7 -20,5 -1.14% | -15,3 |
|
Net income Million EUR | Released Forecast Spread | -19,4 -19,3 -0.73% | -19,7 -20,2 2.48% | -22,1 -21,9 -0.8% | -20,8 -20,6 -0.76% | -15,3 |
|
EPS EUR | Released Forecast Spread | -0,35 -0,35 0% | -0,29 -0,29 0% | -0,29 -0,29 0% | -0,26 -0,26 0% | -0,20 |
| Announcement Date | 26/02/21 | 22/02/22 | 28/02/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,66 0,80 -17.5% | 0,76 1,00 -24% | 0,89 1,60 -44.38% | 0,85 1,10 -22.73% | 0,99 1,30 -24.15% | 0,74 1,00 -25.6% | 0,78 1,00 -22% | 0,64 1,30 -50.69% | 0,40 1,00 -59.9% | 0,94 | 1,18 | 1,09 | 5,95 |
|
EBITDA Million EUR | Released Forecast Spread | -4,80 -6,00 20% | -4,60 -5,00 8% | -5,48 -5,00 -9.68% | -4,19 -6,00 30.17% | -4,78 -3,00 -59.47% | -4,49 -5,00 10.14% | -5,37 -5,00 -7.44% | -4,38 -3,50 -25.14% | -5,35 -4,40 -21.66% | -4,38 | -4,06 | -3,67 | -0,31 |
|
EBIT Million EUR | Released Forecast Spread | -5,40 -5,80 6.9% | -6,07 -4,80 -26.46% | -4,80 -5,60 14.29% | -5,43 -5,40 -0.56% | -5,15 -5,00 -2.96% | -6,10 -5,00 -22.06% | -5,10 -4,20 -21.48% | -6,12 -5,10 -20.04% | -5,13 | -4,90 | -4,50 | -1,20 | |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -5,57 -5,80 4.03% | -6,06 -4,80 -26.15% | -5,15 -5,60 8.02% | -5,57 -5,40 -3.15% | -4,12 -4,20 2% | -5,33 -5,10 -4.53% | -4,50 | -5,60 | -3,50 | -0,40 | |||
|
Net income Million EUR | Released Forecast Spread | -5,60 -6,00 6.67% | -5,30 -5,00 -6% | -6,06 -4,80 -26.21% | -5,16 -5,60 7.86% | -5,57 -5,40 -3.11% | -4,49 -5,00 10.18% | -6,80 -5,00 -36.08% | -4,12 -4,20 1.86% | -5,34 -4,30 -24.16% | -5,13 | -4,90 | -4,50 | 0,52 |
|
EPS EUR | Released Forecast Spread | -0,08 -0,18 55.56% | -0,07 -0,14 50% | -0,08 -0,13 38.46% | -0,07 -0,15 53.33% | -0,07 -0,15 53.33% | -0,06 -0,12 50% | -0,09 -0,12 25% | -0,05 -0,10 50% | -0,07 -0,10 30% | ||||
| Announcement Date | 22/02/22 | 24/05/22 | 25/08/22 | 29/11/22 | 28/02/23 | 25/05/23 | 24/08/23 | 22/11/23 | 29/02/24 | - | - | - | - |
More events
Past sector events for Nanoform Finland Oyj
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NANOFH Stock
- Calendar Nanoform Finland Oyj
